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Abstract
Background: Staphylococcus aureus, particularly methicillin resistant (MRSA), is a common pathogen among
patients receiving hemodialysis. To evaluate nasal carriage, molecular characterization and effectiveness of
decolonization of MRSA among patients receiving hemodialysis in Taiwan, we conducted this study.
Methods: From January to June 2011, two nasal samplings with a 3-month interval were obtained from patients
undergoing hemodialysis in a medical center (CGMH), and in a local hospital (YMH) and sent for detection of MRSA.
For MRSA carriers, decolonization procedures were administered. All patients in CGMH were observed if MRSA
infections occurred during the study period.
Results: A total of 529 nasal specimens (265 from CGMH and 264 from YMH) were collected from 296 patients
(161 from CGMH and 135 from YMH). 233 patients participated in both surveys. Average one-time point MRSA
carriage rate was 3.8%, and the rate was up to 6.9% for those with two-time point surveys. No additional significant
factor for MRSA carriage was identified. Seventy percent of the 20 colonizing MRSA isolates, though categorized as
healthcare-associated strains epidemiologically, shared common molecular characteristics of the local
community-associated strains. Only one of the 20 MRSA-colonized patients failed decolonization and had persistent
colonization, while without any intervention, 17 (61%) of 28 patients with methicillin-sensitive S. aureus colonization
in the first survey had persistent colonization of a genetically indistinguishable strain. Within the study period, two
patients (1.24%) in CGMH, one with MRSA colonization (9.1%), developed MRSA infection.
Conclusion: A substantial proportion of patients receiving hemodialysis in Taiwan had MRSA colonization, mostly
genetically community strains. Decolonization procedures may effectively eliminate MRSA colonization and might
reduce subsequent MRSA infection in these patients.
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Background
Methicillin-resistant S. aureus (MRSA) strains were re-
cently classified as two groups by epidemiologic as well
as molecular characteristics [1], namely community-
associated (CA)- and healthcare-associated (HA)-MRSA.
CA-MRSA isolates are usually less resistant than
HA-MRSA isolates. The transmission of CA-MRSA
clones to healthcare facilities was not only reported
in the U.S.A [2,3], but also in Taiwan [4].
Among patients with end-stage renal disease (ESRD),
bacterial infections are the major cause of morbidity
and mortality during receiving hemodialysis [5] and
Staphylococcus aureus, particularly methicillin-resistant,
is one of the most common pathogens [6,7]. Patients
receiving hemodialysis had a significantly higher risk of
invasive Staphylococcal infection than normal population
[8,9]. Since colonization of S. aureus usually precedes
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clinical infection [10,11], we wondered if the patients
receiving hemodialysis have a higher rate of MRSA car-
riage. In addition, decolonization of MRSA carriage
with topical mupirocin and chlorhexidine bathing has
been well discussed [12-14] recently, but inconclusive,
including in the patients receiving hemodialysis. Hence,
we conducted a study to evaluate the carriage rate of
MRSA, molecular characterization of these MRSA iso-
lates as well as the effectiveness of decolonization pro-
cedures among the patients receiving hemodialysis in
both a medical center and a local hospital in Taiwan.
Methods
This study was approved by the institutional review
board of Chang Gung Memorial Hospital and a written
informed consent was obtained from each subject.
Hospitals and patients population
The study was conducted in two hospital-based out-
patient hemodialysis clinics at Chang Gung Memorial
Hospital (CGMH) and Yang Ming Hospital (YMH) from
January 2011 to June 2011. Both hospitals are situated in
northern Taiwan. CGMH is a university-affiliated medical
center with 51 beds in the outpatient hemodialysis clinic
while YMH is a local hospital, providing primary care,
with 36 beds in outpatient hemodialysis clinic. In January
2011, all 290 and 150 patients receiving maintenance
hemodialysis at CGMH and YMH, respectively, were eli-
gible for and invited to participate in this study. Nasal
samplings from the participants were conducted in Janu-
ary (first survey) and March (second survey), 2011, re-
spectively. Only the study patients in CGMH were
observed if MRSA infections occurred during the study
period.
Data collection
To identify the potential risk factors for MRSA ac-
quisition, the following information were collected from
medical records of the participants at both hospitals:
demographics, underlying disease, latest hospitalization,
length of time on hemodialysis, blood access of dia-
lysis (Hickman, arteriovenous fistula, Gortex), previous
S. aureus infection, and usage of other catheters (Foley
and tracheostomy tube).
Microbiologic methods
Each nasal swab was circled the anterior 1 cm of the
nasal vestibule of both participant’s nares. The sam-
ples, then, were placed into the transport medium
(Venturi Transystem, Copan Innovation Ltd.) immedi-
ately. Swab samples were inoculated by streak plate
method onto Trypticase soy agar with 5% sheep blood
plates. Those plates were incubated at 37 degree Celsius
overnight. Identification of S. aureus was done by
conducting morphology, gram stain, and coagulase tests
of strains grown on agar plates. To identify MRSA,
cefoxitin disk was used by disk-diffusion method accord-
ing to the recommendation of Clinical and Laboratory
Standard Institutes [15].
Antimicrobial susceptibility study
The antimicrobial susceptibility of all MRSA isolates
to 10 antibiotics, including oxacillin, trimethoprim/
sulfamethoxazole (SXT), penicillin, teicoplanin, linezolid,
clindamycin, doxycyclin, fusidic acid, vancomycin, and
erythromycin, was tested in accordance with the guide-
line of Clinical and Laboratory Standard Institutes [15]
by using the disk-diffusion method.
Molecular characterization
All the MRSA isolates were molecularly characterized,
and the molecular methods used included pulsed-field
gel electrophoresis (PFGE) with SmaI digestion,
staphylococcal chromosomal cassette mec (SCCmec)
typing [16], multilocus sequence type (MLST), and spa
gene typing [17]. In addition, the presence of Panton-
Valentine leukocidin (PVL) genes [18] was also exam-
ined. The details of the procedures were described else-
where previously [16-21]. The genotypes of PFGE were
designated, as in our previous studies [19,20], in alpha-
betical order; any new type, if identified, was designated
consecutively. PFGE patterns with < 4-band differences
from an existing genotype were defined as subtypes. Two
isolates were considered to be indistinguishable, highly
related, or distinct if they had the same subtype (no band
difference), the same genotype (< 4-band differences), or
a different type (≥ 4-band differences), respectively.
MLST was examined for selective strains of representa-
tive PFGE patterns [21].
For those with MSSA isolates from both surveys,
PFGE method was used to examine the genetic related-
ness of paired isolates from the same subject.
Intervention and follow-up
Decolonization procedures, intranasal mupirocin oint-
ment twice daily and 2% chlorhexidine shampoo once
daily for five days [13,14], were applied to the patients
with MRSA colonization after identified. After the
decolonization procedures, a follow-up sampling from
the nares was obtained one week later.
Statistical analysis
Comparing MRSA colonization between two hospitals
was done using Pearson’s chi-square tests. Continuous
variables were compared between patients with MRSA
colonization versus patients without MRSA colonization
using Student t test. The categorical variables were
analyzed by chi-square test or Fisher’s exact test, as
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appropriate. Odd ratios (ORs) were also calculated
with 95% confidence intervals (CIs). The definition of
statistical significance was p <0.05. For statistical ana-
lysis, SPSS 17.0 software was used.
Results
A total of 529 nasal specimens (265 from CGMH and 264
from YMH) were collected from 296 patients (161 from
CGMH and 135 from YMH). Totally, 104 subjects in
CGMH and 129 subjects in YMH participated in both sur-
veys. 116 patients in CGMH participated in the first survey,
among whom 12 patients withdrew for the second survey,
while additional 45 patients participated in the second sur-
vey. 129 patients in YMH participated in both surveys, and
additional 6 patients participated in the second survey.
The prevalence rates of MSSA and MRSA carriage
among the subjects are shown in Table 1. The overall nasal
MSSA and MRSA colonization rate was 11.7% and 4.2%,
respectively in CGMH and 12.5% and 3.4%, respectively in
YMH. The carriage rates for the patients receiving both
surveys were similar by batch survey but the rate of MSSA
and MRSA carriage was up to 15.9% and 6.9%, respectively,
if either specimen from each subject was positive (Table 1).
No significant difference was found in terms of nasal MSSA
and MRSA carriage rate between two hospitals.
The comparison of demographics and clinical charac-
teristics between patients with and without MRSA
colonization are shown in Table 2. No significant factors
associated with MRSA colonization was identified, in-
cluding sex distribution, age distribution, duration of
dialysis, underlying disease, blood access etc., neither
was MSSA colonization. The data from CGMH only also
showed that no significant difference was observed in
terms of previous MSSA or MRSA infection within one
year, and antibiotics usage within one month (detailed
data not shown).
Twenty MRSA isolates from 19 subjects were available
for molecular characterization and are shown in Table 3.
Six PFGE patterns were identified. All isolates carried
either SCCmec type IV, V, or VT. PFGE pattern D/
sequence type (ST) 59 or 338/spa type 437/SCCmec VT
and PFGE pattern C/ST 59/spa type 437/ C with
spa gene type 437/SCCmec IV were the two most
common clones, both belonging to endemic community-
associated (CA) clones in Taiwan. All the MRSA strains
were resistant to penicillin and susceptible to linezoid,
teicoplanin, and vancomycin. The susceptibility rates to
erythormycin, doxycyclin, clindamycin, trimethoprim-
sulfamethoxazole (TMP-SMX), and fusidic acid were
30%, 95%, 40%, 95%, and 90%, respectively.
After the first survey, all 9 MRSA carriers received
decolonization procedures and follow-up samplings
revealed negative for MRSA in eight carriers. After the
second survey, all 11 MRSA carriers were successfully
decolonized. The carrier without successful decolonization
after the first survey still had MRSA colonization in the
second survey and successfully decolonized subsequently.
For this patient, the two isolates from both surveys
were indistinguishable and characterized as ST338/
PFGE D/SCCmec VT/PVL-positive and the isolate from
follow-up sampling after the first decolonization also
had the same PFGE type.
In contrast, of the 233 patients participating in both
surveys, 18 (64%) of 28 with MSSA colonization in the
first survey still had MSSA colonization in the second
survey. Of the 36 MSSA isolates from 18 subjects with
paired isolates, 10 PFGE patterns were identified. Paired
isolates from the same patient were indistinguishable for
17 of the 18 patients.
During the study period, two (1.24%) of 161 patients
in CGMH, one with MRSA colonization (9.1%), developed
MRSA infection. The clinical isolate was not preserved and
not available for comparison of genetic relatedness with
Table 1 Nasal carriage of methicillin-resistant S. aureus (MRSA) and methicillin-susceptible S. aureus (MSSA) among
patients receiving hemodialysis in Taiwan, stratified by patients receiving individual survey or both surveys
Colonization CGMH YMH Total
Individual Both Individual Both Individual Both
Subject No. of 1st sampling 116 104 129 129 245 233
MSSA 14 (12.1) 12 (11.5) 16 (12.4) 16 (12.4) 30 (12.2) 28 (12)
MRSA 6 (5.2) 6 (5.8) 3 (2.3) 3 (2.3) 9 (3.7) 9 (3.9)
Subject No. of 2nd sampling 149 104 135 129 284 233
MSSA 17 (11.4) 10 (9.6) 17 (12.6) 17 (13.2) 34 (12.0) 27 (11.6)
MRSA 5 (3.4) 3 (2.9) 6 (4.4) 5 (3.9) 11 (3.9) 8 (3.4)
Total No. of samplings 265a 104b 264a 129b 529a 233b
MSSA 31 (11.7) 13c (12.5) 33 (12.5) 24c (18.6) 64 (12.1) 37c (15.9)
MRSA 11 (4.2) 8c (7.7) 9 (3.4) 8c (6.2) 20 (3.8) 16c (6.9)
CGMH: Chang Gung Memorial Hospital, YMH: Yang Ming Hospital, aby samplings number, bby subjects number, cat least one positive specimen.
No significant difference was found for carriage rate of MSSA or MRSA between two hospitals by Fisher’s exact test.
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Table 2 Demographics and clinical characteristics of hemodialysis patients with and without methicillin-resistant S.
aureus (MRSA) colonization






valueaTotal (n=296) MRSA (n=19) Non-MRSA (n=277)
Male 136(45.9) 6(31.6) 130(46.9) 0.522 0.193~1.413 0.194
Age
19-29 6(2.0) 0 6(2.1) 0.934 0.906~0.963 1.000
30-59 155(52.4) 10(52.6) 145(52.3) 1.011 0.399~2.566 0.981
≥60 135(45.6) 9(47.4) 126(45.5) 1.079 0.425~2.737 0.873
Underlying diseases
DM 125(42.2) 11(57.9) 114(41.2) 1.966 0.767~5.041 0.153
Hypertension 194(65.5) 16(84.2) 178(64.3) 2.920 0.830~10.268 0.081
HBV carrier 32(10.8) 0 32(11.6) 0.928 0.897~0.960 0.241
HCV carrier 46(15.5) 2(10.5) 44(15.9) 0.620 0.138~2.781 0.406
Liver cirrhosis 8(2.7) 0 8(2.3) 0.934 0.905~0.963 1.000
Gastric ulcer 92(31.1) 5(26.3) 87(31.4) 0.780 0.272~2.234 0.643
History of GI bleeding 26(8.8) 3(15.8) 23(8.3) 2.071 0.562~7.635 0.226
Asthma 2(0.7) 0 2(0.7) 0.935 0.908~0.964 1.000
History of TB infection 5(1.7) 0 5(1.8) 0.935 0.907~0.964 1.000
COPD 16(5.4) 0 16(5.8) 0.932 0.903~0.962 0.610
Cancer 25(8.4) 1(5.3) 24(8.7) 0.586 0.075~4.580 1.000
Current disease
Pneumonia 3(1.0) 0 3(1.1) 0.935 0.907~0.964 1.000
URTI 51(17.2) 4(21.1) 47(17.0) 1.305 0.415~4.108 0.752
Other risk factors
Hospitalization c 95(32.1) 4(21.1) 91(35.0) 0.545 0.176~1.689 0.287
Previous S. aureus infection c,d 42(14.2) 4(21.1) 38(13.7) 1.677 0.529~5.323 0.325
S. aureus skin infection c,d,e 13(4.4) 1(5.3) 12(4.3) 1.227 0.151~9.970 0.586
Previous catheter related infectionc 34(11.5) 3(15.8) 31(11.2) 1.488 0.410~5.397 0.467
Using of immunosuppressant 18(6.1) 2(10.5) 16(5.8) 1.919 0.407~9.039 0.324
Alcohol drinking 24(8.1) 0 24(8.7) 0.930 0.900~0.961 0.381
Average duration of HD(year)b 7.03±0.35 5.60±1.28 7.13±0.36 0.289
Duration > 3 years 11(57.9) 195(70.4) 206(69.6) 0.578 0.224~1.490 0.252
Duration > 5 years 8(42.1) 152(54.9) 160(54.1) 0.598 0.233~1.533 0.280
Blood access
Hickman 22(7.4) 1(5.3) 21(7.6) 0.677 0.086~5.326 1.000
A-V fistula 180(60.8) 11(57.9) 169(61.0) 0.879 0.342~2.254 0.788
Gortex 94(31.8) 7(36.8) 87(31.4) 1.274 0.485~3.347 0.623
Other catheter f 8(2.7) 2(10.5) 6(2.2) 5.314 0.997~28.331 0.087
DM: diabetes mellitus, HBV: hepatitis B virus , HCV: hepatitis C virus, GI: gastrointestinal, TB: tuberculosis, COPD: chronic obstructive pulmonary disease, URTI:
upper respiratory tract infection, inf.: infection, HD: hemodialysis, A-V: arterial venous.
a For categorical variables, Fisher’s exact test was used for extreme proportions (expected count <5) instead of Pearson’s chi-square test.
b data was presented as the mean value ± standard error of the mean for continuous variables. Performed by Student t test.
c any event happened in one year before sampling.
d including general S. aureus infection without known susceptibility or resistance of antibiotics.
e including impetigo, furuncle, carbuncle, cellulitis, and abscess.
f including Foley and tracheostomy tube.
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the colonization isolate. With decolonization procedures
applied to those with MRSA colonization, no significant
difference was found between the patients with and with-
out MRSA colonization for subsequent MRSA infection.
Discussion
Results from this study showed that the mean one-
time point MRSA carriage rate of patients receiving
hemodialysis in northern Taiwan was 3.8%, and the
rate was up to 6.9% for those receiving two-time point
surveys. For patients receiving hemodialysis, the nasal
MRSA carriage rate was different, with a wide range, in
different countries and regions, and also different with
the different number of samplings. In previous reports
from Taiwan, the average one-time point MRSA carriage
rate among patients receiving hemodialysis was 2.4%
(of 509 patients) in a report from southern Taiwan [22],
and the rate was up to 9.5% of 306 patients with two
serial surveys in another study from northern Taiwan
[23]. Both rates were comparable to those in the
present study.
For one-time point survey, the rate of nasal MRSA car-
riage (3.8%) among the patients receiving hemodialysis in
the present study was also similar to that of adult
patients visiting emergency room (3.8% of 502 patients)
[20] and that of adults for health examination (3.8% of
3098 adults) reported from Taiwan [24]. Since most of
the patients receiving hemodialysis came from commu-
nity settings and both out-patient hemodialysis clinics
were located in independent spaces of both hospitals,
these patients were not frequently exposed to the
patients with at-risk for MRSA acquisition, such as
patients in intensive care units (ICU).
In the present study, we also found that no significant
difference for nasal S. aureus, either MSSA or MRSA,
carriage rate was found between patients treated at the
medical center and the local hospital. Though the
patients receiving hemodialysis may be associated with
an increased risk of MSSA or MRSA colonization
[20,25,26], no additional significant risk factor for S. aur-
eus was identified among patients receiving hemodialysis
in the present study. No significant difference was found,
either, between the isolates from both hospitals in terms
of antibiotics susceptibilities and molecular characteris-
tics. These results suggest that the characteristics of the
patients as well as the environments of out-patient
hemodialysis at a local hospital and a medical center in
northern Taiwan were similar.
Molecular characterization of all MRSA isolates in the
present study showed that 70% of the isolates shared a
common characteristics of endemic CA-MRSA clones
(ST 59 or its single locus variant, 338) in Taiwan [4].
The remaining 6 isolates carried type IV or V SCCmec,
also suggesting community strains [27]. The scenario of
community strains being transmitted to healthcare facil-
ities was indicated. The patient with the isolate of ST 30
had a travel history to other Asian countries, where the
strains of ST 30 prevailed in the community; whether
the patient acquired the isolate abroad needs further
studies.
Scanty studies assessed the effect of MRSA decolonization
for patients receiving hemodialysis and indicated that these
patients might benefit from decolonization, though repeated
courses of treatment are needed and the effects are modest
[28]. In the present study, only one of 9 MRSA colonizers
without successful elimination was persistent colonizer; in
contrast, without elimination procedures, nearly two-thirds
of 28 MSSA colonizations were persistent. Furthermore,
with successful decolonization for most colonizers, no sig-
nificant difference was found between the patients with and
without MRSA colonization for subsequent MRSA infec-
tion, though the size of the patient’s number was small.
These findings support that patients receiving hemodialysis
with MRSA colonization may be successfully decolonized
with intranasal mupirocin treatment plus chlorhexidine
bath and might benefit from the reduction of subsequent
MRSA infection to a rate comparable to that among
those without MRSA colonization. The issue whether
decolonization of MRSA may reduce subsequent infection
in this population needs a large scale randomized control
study.
There are several limitations for the present study.
First, less than 60%, lower than expected, of the patients
receiving hemodialysis in CGMH participated in this
Table 3 Distribution of pulsed-field gel electrophoresis (PFGE) patterns and other molecular characterization of all 20
methicillin-resistant S. aureus isolates
PFGE pattern No. (%) of isolates SCCmec type Presence of PVL genes MLST type spa gene type
C 5 (25) IV 1 59 t0437
D 9 (45) VT 8 59,338 t0437
AG 1 (5) IV 0 30 t019
BR 1 (5) IV 0 8 t008
BM 3 (15) V 0 45 t1081
U 1 (5) IV 0 573 t3525
SCCmec, staphylococcal chromosomal cassette mec; MLST, multilocus sequence type; PVL, Panton-Valentine leukocidin.
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study, which reduced the size of case number for evalu-
ation and indirectly affected the analysis of statistic sig-
nificance. Second, from each study subject, samplings for
MRSA detection were obtained only from one site
(nares) once or twice, so some MRSA colonizing patients
might be undetected [29]. Third, for each patient receiv-
ing de-colonization therapy, only one follow-up sampling
was obtained one week after treatment, which might be
inadequate for the proof of successful decolonization
[30,31]. It is an issue that how many follow-up samplings
and how long the observation duration are adequate for
the proof of successful decolonization.
Conclusions
A substantial proportion of patients receiving hemo-
dialysis in Taiwan had MRSA colonization, mostly genetic-
ally community strains. No additional significant factor
for MRSA carriage was identified among these patients.
Decolonization procedures with intranasal mupirocin
treatment plus chlorhexidine bath for 5 days may effect-
ively eliminate MRSA colonization and might reduce sub-
sequent MRSA infection in these patients.
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